
 
 
 
 
 
 
 
 
 What is claimed is:  
   
 1. A method for treatment of graft rejection in a mammal comprising administering tautomycetin or its pharmaceutially acceptable salt to said mammal in need of treatment of graft rejection by injection into a vein or muscle at 0.01 to 0.5 mg/kg/day. 
 
     
 2. The method of  claim 1 , wherein the salt is formed by treating alkali metal or alkali earth metal alkoxide with tautomycetin. 
 
     
 3. The method of  claim 2 , wherein the alkali metal is sodium or potassium. 
 
     
 4. The method of  claim 2 , wherein the alkali earth metal alkoxide is selected from the group consisting of sodium methoxide, sodium ethoxide, and potassium t-butoxide. 
 
   
 
 
 
 
 
 
 
 
